Position in ACET
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,078,548
+$274,029 QoQ
Shares Held
124,832
+5.7% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 56 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. ACET ranks #63 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in ACET
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,078,548 | 124,832 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $804,519 | 118,138 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,527,345 | 181,395 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,835,047 | 2,265,491 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,265,508 | 2,074,604 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $1,539,689 | 2,039,324 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $1,926,931 | 2,003,047 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,707,103 | 1,879,933 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,312,962 | 1,085,093 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $835,056 | 355,343 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,057,927 | 559,750 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $716,522 | 523,009 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $55,681 | 22,914 | Shares | Defined | 2023-08-07 | |
| 2021-06-30 | $49,834 | 4,843 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $541,786 | 41,421 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $631,280 | 44,931 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,274,215 | 107,167 | Shares | Defined | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||